NatureWise Biotech & Medicals Corporation (TPEX:4732)
Taiwan · Delayed Price · Currency is TWD 19.00
-0.05 (-0.26%)
May 29, 2026, 1:11 PM CST
TPEX:4732 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 895 | 975 | 1,230 | 1,343 | 1,737 | 2,534 | |
Market Cap Growth | -6.75% | -20.71% | -8.42% | -22.70% | -31.42% | 109.96% |
Enterprise Value | 453 | 436 | 745 | 830 | 1,225 | 2,072 |
Last Close Price | 19.05 | 20.75 | 25.00 | 23.73 | 30.17 | 43.55 |
PE Ratio | - | - | 1371.24 | 132.72 | 57.87 | 82.24 |
PS Ratio | 5.07 | 5.52 | 5.48 | 8.39 | 7.60 | 10.14 |
PB Ratio | 1.40 | 1.52 | 1.57 | 2.12 | 2.71 | 4.06 |
P/TBV Ratio | 1.50 | 1.63 | 1.73 | 2.25 | 2.90 | 4.39 |
P/FCF Ratio | - | - | - | 21.70 | 125.42 | 75.14 |
P/OCF Ratio | - | - | - | 21.59 | 125.42 | 75.14 |
EV/Sales Ratio | 2.56 | 2.47 | 3.32 | 5.18 | 5.36 | 8.29 |
EV/EBITDA Ratio | - | - | - | 84.38 | 32.99 | 54.51 |
EV/EBIT Ratio | - | - | - | 241.67 | 46.51 | 76.80 |
EV/FCF Ratio | -4.02 | - | - | 13.41 | 88.45 | 61.45 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.00 | 0.01 | 0.00 | 0.01 |
Debt / EBITDA Ratio | - | - | - | 0.56 | 0.07 | 0.17 |
Debt / FCF Ratio | - | - | - | 0.13 | 0.20 | 0.20 |
Net Debt / Equity Ratio | -0.72 | -0.72 | -0.78 | -0.74 | -0.77 | -0.79 |
Net Debt / EBITDA Ratio | 4.79 | 4.79 | 109.75 | -47.53 | -13.23 | -12.92 |
Net Debt / FCF Ratio | 4.08 | 4.08 | 209.86 | -7.55 | -35.46 | -14.57 |
Asset Turnover | 0.23 | 0.23 | 0.29 | 0.23 | 0.33 | 0.37 |
Inventory Turnover | 1.11 | 1.11 | 1.25 | 1.02 | 1.71 | 2.22 |
Quick Ratio | 8.92 | 8.92 | 13.35 | 9.81 | 13.03 | 8.24 |
Current Ratio | 10.66 | 10.66 | 15.28 | 11.55 | 14.52 | 9.12 |
Return on Equity (ROE) | -16.63% | -16.63% | -0.51% | 1.59% | 4.74% | 5.04% |
Return on Assets (ROA) | -8.60% | -8.60% | -0.98% | 0.31% | 2.36% | 2.47% |
Return on Invested Capital (ROIC) | -58.76% | -60.36% | -7.10% | 2.17% | 18.60% | 20.59% |
Return on Capital Employed (ROCE) | -16.40% | -16.40% | -1.50% | 0.50% | 4.10% | 4.20% |
Earnings Yield | -10.31% | -9.46% | 0.07% | 0.75% | 1.73% | 1.22% |
FCF Yield | -12.57% | -11.54% | -0.24% | 4.61% | 0.80% | 1.33% |
Dividend Yield | - | - | - | 0.84% | 1.66% | 0.69% |
Payout Ratio | - | - | 1098.88% | 243.53% | 49.25% | 15.09% |
Buyback Yield / Dilution | -8.87% | 2.02% | 0.15% | -0.85% | -0.30% | 0.05% |
Total Shareholder Return | -8.87% | 2.02% | 0.15% | -0.01% | 1.36% | 0.74% |